The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for N Patel


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of Glaucoma.EBI
Lexicon Pharmaceuticals
A fluorescent reporter of ATP binding-competent receptor kinases.EBI
University of Miami
Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened.EBI
TBA
Structure-activity relationships of some opiate glycosides.EBI
Ultrafine Ufc
Novel 3-Aryl Indoles as Progesterone Receptor Antagonists for Uterine FibroidsEBI
TBA
Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucoma.EBI
Lexicon Pharmaceuticals
PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments.EBI
University of California-San Diego
Defining Target Engagement Required for Efficacy EBI
Lilly Research Laboratories
Synthesis and evaluation of a 125I-labeled iminodihydroquinoline-derived tracer for imaging of voltage-gated sodium channels.EBI
Institute of Nuclear Medicine
Discovery of 5-substituted 2-amino-4-chloro-8-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-7,8-dihydropteridin-6(5H)-ones as potent and selective Hsp90 inhibitors.EBI
Poniard Pharmaceuticals